Atlas Trials

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

Clinical trial NCT06503107 · RECRUITING

Trial details

NCT number
NCT06503107
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2024-04-23
Primary completion
2026-04-18
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.